Effect of inflammation on cytokine levels and bone remodelling markers in peri-implant sulcus fluid: A preliminary report

Cytokine

Volumn 59, Issue 2, 2012, Pages 313-316

  Güncü, Güliz N ^a   Akman, Abdullah C ^a   Günday, Sevim ^a   Yamalik, Nermin ^a   Berker, Ezel ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

IL 1 ; IL 10; OPG; Peri implant sulcus fluid; RANKL

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ADULT; ARTICLE; BODY FLUID; BONE REMODELING; BONE STRUCTURE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA BLEEDING; GINGIVITIS; HUMAN; MALE; PERIIMPLANTITIS; PERIODONTITIS; PRE IMPLANT SULCUS FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; TOOTH IMPLANTATION; VOLUMETRY;

ADULT; AGED; BIOLOGICAL MARKERS; BODY FLUIDS; BONE REMODELING; CYTOKINES; DENTAL IMPLANTS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; OSTEOPROTEGERIN; RANK LIGAND;

EID: 84862331802     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.04.024     Document Type: Article

References (33)

1. Stashenko P., Dewhirst F.E., Peros W.J., Kent R.L., Ago J.M. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987, 138:1464-1468.
2. Lacey D.L., Timms E., Tan H.-L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
3. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
4. Claudino M., Trombone A.P., Cardoso C.R., Ferreira S.B., Martins W., et al. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 2008, 84:1565-1573.
5. Kearns A.E., Khosla S., Kostenuik P.J. Receptor activator of nuclear factor kappab ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev 2008, 29:155-192.
6. Nakagawa N., Kinosaki M., Yamaguchi K., Shima N., Yasuda H., Yano K., et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 1998, 253:395-400.
7. Liu C., Walter T.S., Huang P., Zhang S., Zhu X., et al. Structural and functional insights of RANKL-RANK interaction and signaling. J Immunol 2010, 184:6910-6919.
8. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel-secreted protein involved in the regulation of bone density. Cell 1997, 89:309-319.
9. Kong Y.Y., Boyle W.J., Penninger J.M. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol Today 2000, 21:495-502.
10. Teng Y.T., Nguyen H., Gao X., Kong Y.Y., Gorczynski R.M., et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 2000, 106:R59-R67.
11. Lu H.-K., Chen Y.-L., Chang H.-C., Li C.-L., Kuo M.Y.-P. Identification of the osteoprotegerin/receptor activator of nuclear factor kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. J Periodontal Res 2006, 41:354-360.
12. Mogi M., Otogoto J., Ota N., Togari A. Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. J Dent Res 2004, 83:166-169.
13. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004, 22:929-979.
14. Meffert R.M. Periodontitis vs. peri-implantitis: the same disease? The same treatment?. Crit Rev Oral Biol Med 1996, 7:278-291.
15. Adonogianaki E., Mooney J., Wennstrom J.L., Lekholm U., Kinane D.F. Acute-phase proteins and immunoglobulin G against Porphyromonas gingivalis in peri-implant crevicular fluid: a comparison with gingival crevicular fluid. Clin Oral Implants Res 1995, 6:14-23.
16. Salvi G.E., Lang N.P. Diagnostic parameters for monitoring peri-implant conditions. Int J Oral Maxillofac Implants 2004, 19(Suppl):116-127.
17. Guncu G.N., Tozum T.F., Guncu M.B., Yamalik N., Tumer C., Karabulut E., et al. Myeloperoxidase as a measure of polymorphonuclear leukocyte response in inflammatory status around immediately and delayed loaded dental implants: a randomized controlled clinical trial. Clin Implant Dent Relat Res 2008, 10:30-39.
18. Tozum T.F., Guncu G.N., Yamalik N., Turkyilmaz I., Guncu M.B. The impact of prosthetic design on the stability, marginal bone loss, peri-implant sulcus fluid volume, and nitric oxide metabolism of conventionally loaded endosseous dental implants: a 12-month clinical study. J Periodontol 2008, 79:55-63.
19. Tumer C., Aksoy Y., Guncu G.N., Nohutcu R.M., Kilinc K., Tozum T.F. Possible impact of inflammatory status on C-telopeptide pyridinoline cross-links of type I collagen and osteocalcin levels around oral implants with peri-implantitis: a controlled clinical trial. J Oral Rehabil 2008, 35:934-939.
20. Loe H., Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963, 21:533-551.
21. Silness J., Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964, 22:121-135.
22. Nowicki D., Vogel R.I., Melcer S., Deasy M.J. The gingival bleeding time index. J Periodontol 1981, 52:260-262.
23. Preshaw P.M. Host response modulation in periodontics. Periodontol 2000, 2008(48):92-110.
24. Ataoglu H., Alptekin N.O., Haliloglu S., Gursel M., Ataoglu T., Serpek B., et al. Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res 2002, 13:470-476.
25. Murata M., Tatsumi J., Kato Y., Suda S., Nunokawa Y., Kobayashi Y., et al. Osteocalcin, deoxypyridinoline and interleukin-1beta in peri-implant crevicular fluid of patients with peri-implantitis. Clin Oral Implants Res 2002, 13:637-643.
26. Panagakos F.S., Aboyoussef H., Dondero R., Jandinski J.J. Detection and measurement of inflammatory cytokines in implant crevicular fluid: a pilot study. J Oral Maxillofac Implants 1996, 11:794-799.
27. Bozkurt F.Y., Yetkin Ay Z., Berker E., Tepe E., Akkus S. Anti-inflammatory cytokines in gingival crevicular fluid in patients with periodontitis and rheumatoid arthritis: a preliminary report. Cytokine 2006, 35:180-185.
28. Johannsen A., Bjurshammar N., Gustafsson A. The influence of academic stress on gingival inflammation. Int J Dent Hyg 2010, 8:22-27.
29. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
30. Duarte P.M., de Mendonca A.C., Maximo M.B., Santos V.R., Bastos M.F., Nociti F.H. Differential cytokine expressions affect the severity of peri-implant disease. Clin Oral Implants Res 2009, 20:514-520.
31. Cochran D.L. Inflammation and bone loss in periodontal disease. J Periodontol 2008, 79(8 Suppl):1569-1576.
32. Yalcin S., Basegmez C., Mijiritsky E., Yalcin F., Isik G., Onan U. Detection of implant crevicular fluid prostaglandin E2 levels for the assessment of peri-implant health: a pilot study. Implant Dent 2005, 14:194-200.
33. Rudin H.J., Overdiek H.F., Rateitschak K.H. Correlation between sulcus fluid rate and clinical and histological inflammation of the marginal gingiva. Helv Odontol Acta 1970, 14:21-26.